Immunomedics Inc (IMMU) Stock Analyst Ratings
NASDAQ:IMMU - Nasdaq -
ChartMill assigns a Buy % Consensus number of 77% to IMMU. The Buy consensus is the weighted average rating of the current analysts ratings.
IMMU was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about IMMU.
In the previous month the buy percentage consensus was at a similar level.
IMMU was analyzed by 7 analysts. More opinions would make the average more meaningful.